These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1530786)

  • 1. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure.
    Tomiya T; Nagoshi S; Fujiwara K
    Hepatology; 1992 Jan; 15(1):1-4. PubMed ID: 1530786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Kimoto M; Kawakami S; Miyoshi H; Kubozono O
    Dig Dis Sci; 1991 Jun; 36(6):780-4. PubMed ID: 1827761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Takahashi K; Koura M; Hashimoto S; Daikuhara Y
    Exp Cell Res; 1986 Sep; 166(1):139-50. PubMed ID: 3527727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. Basic aspects.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Arakaki N; Yamamoto I; Hashimoto S; Daikuhara Y
    Dig Dis Sci; 1991 Jun; 36(6):785-90. PubMed ID: 1827762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination and clinical significance of human hepatocyte growth factor in serum].
    Takemura M; Furuta N; Nakamura S; Okuno M; Seishima M; Noma A; Sugihara J; Murakami N; Sugiyama H; Moriwaki H
    Rinsho Byori; 1992 Nov; 40(11):1168-72. PubMed ID: 1307623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.
    Ho DW; Fan ST; To J; Woo YH; Zhang Z; Lau C; Wong J
    Gut; 2002 Jun; 50(6):869-76. PubMed ID: 12010892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepatocyte growth factor levels in patients with chronic renal failure.
    Sugimura K; Kim T; Goto T; Kasai S; Takemoto Y; Matsuda J; Yoshimoto M; Yamagami S; Kishimoto T
    Nephron; 1995; 70(3):324-8. PubMed ID: 7477621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocyte stimulatory peptide and its clinical significance in viral hepatitis].
    Zhou WP; Zhang DF; Ren H
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):626-8, 658. PubMed ID: 1306456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocyte growth factor in sera from patients with fulminant hepatic failure].
    Nakayama H; Tsubouchi H; Hirono S; Takahashi K; Miyazaki H
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2857. PubMed ID: 4087488
    [No Abstract]   [Full Text] [Related]  

  • 16. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor in fulminant hepatic failure.
    Hughes RD; Gove CD; Williams R
    Hepatology; 1990 Feb; 11(2):332-3. PubMed ID: 2137808
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration in levels of human hepatocyte growth factor following hepatectomy.
    Nishizaki T; Takenaka K; Yoshizumi T; Yanaga K; Soejima Y; Shirabe K; Sugimachi K
    J Am Coll Surg; 1995 Jul; 181(1):6-10. PubMed ID: 7599773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
    Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J
    J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.
    Ljubimova JY; Petrovic LM; Arkadopoulos N; Blanc P; Geller SA; Demetriou AA
    Dig Dis Sci; 1997 Aug; 42(8):1675-80. PubMed ID: 9286233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.